ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 80 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $527,000 | +160.9% | 113,437 | +85.3% | 0.00% | +50.0% |
| Q4 2020 | $202,000 | -2.4% | 61,218 | -2.3% | 0.00% | -33.3% |
| Q3 2020 | $207,000 | -57.6% | 62,645 | -56.7% | 0.00% | -62.5% |
| Q2 2020 | $488,000 | +369.2% | 144,760 | +739.0% | 0.01% | +700.0% |
| Q4 2019 | $104,000 | +15.6% | 17,254 | +44.9% | 0.00% | 0.0% |
| Q3 2019 | $90,000 | -32.3% | 11,909 | -51.3% | 0.00% | 0.0% |
| Q1 2019 | $133,000 | +9.9% | 24,453 | +64.5% | 0.00% | 0.0% |
| Q3 2018 | $121,000 | -9.7% | 14,861 | +8.1% | 0.00% | -50.0% |
| Q2 2018 | $134,000 | -46.0% | 13,742 | -30.7% | 0.00% | -50.0% |
| Q4 2017 | $248,000 | – | 19,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |